April 1, 2024 · Form 4 insider transaction
Mandadi Tilak bought 67,920 shares of CVS Health Corporation at $79.56 per share, a transaction worth $5.40M. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Option becomes exercisable in four equal annual installments, commencing 4/1/2025.